Could a popular Weight-Loss shot also cool hot flashes and turn back the clock?
NCT ID NCT07218445
Summary
This Mayo Clinic study is testing if tirzepatide (a medication approved for weight loss) can reduce the frequency and severity of bothersome hot flashes in postmenopausal women with obesity. It will also check if the drug affects measures of biological aging and heart health. The study involves 40 participants who will receive either the drug or a placebo for 24 weeks while following a diet and exercise plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.